Xeljanz Lawsuits
Side effects of Xeljanz linked to risk of cancer, heart attacks, pulmonary embolism, deep vein thrombosis, blood clots and death.
Search Results For: Xeljanz
-
-
Side Effects of Xeljanz, Rinvoq and Similar Drugs May Increase Risk of Acne: Study
A new study links Xeljanz, Rinvoq and similar drugs to an increased risk of developing acne.
-
Cancer Risk with Xeljanz, Other JAK Inhibitors Higher Than Among Users of Older TNF Inhibitors
-
EMA Calls for Restricted Use of Xeljanz, Rinvoq, Similar Drugs Due to Heart, Cancer, Blood Clot and Infection Risks
European regulators urge doctors to limit the use of Xeljanz and similar drugs among certain patients more prone to heart problems and blood clots.
-
Study Questions Whether Side Effects of Xeljanz, Similar Drugs, Increase Blood Clot Risks
A new study raises doubts about whether Xeljanz and similar drugs increase the risk of blood clots.
-
Xeljanz Infection Risk Higher Than TNF Inhibitors: Study
Xeljanz use carries a higher infection risk than other arthritis drugs, like Humira, according to the findings of a new study.
-
Skin Cancer Risk Linked to Xeljanz, Jakafi, Other JAK Inhibitors: Study
A new study links Xeljanz and similar drugs to an increased risk of skin cancer.
-
Xeljanz Stroke Lawsuit Filed Against Pfizer for Gross Negligence in Failing to Warn About Drug Risks
A Xeljanz stroke lawsuit claims Pfizer failed to adequately warn about the drug's heart risks.
-
Xeljanz Lawsuit Filed Over Failure to Warn About Risk of Blood Clots, Pulmonary Embolisms
A Xeljanz lawsuit claims Pfizer misled the public about the safety of the rheumatoid arthritis drug, leading to a man suffering a life-threatening blood clot.
-
Xeljanz Side Effects Linked to Higher Risk of Serious Heart Problems and Cancer, Study Finds
Another study has linked Xeljanz with an increased risk of serious heart problems and cancer, as well as opportunistic infections.